|
Brain feed |
|
FT.com - Drugs and Healthcare
|
FT.com - Drugs and Healthcare
|
|
-
Southern Cross chief departs as sell-off continues
Bill Colvin, chief executive of Southern Cross, the care home group, is to step down
-
Montagu puts BSN Medical up for auction
Planned ?1.8bn-?1.9bn sale would be the latest in a string of deals in the wound-care industry after Bristol-Myers Squibb sold its ConvaTec business to private equity and Johnson & Johnson received a bid for Ethicon
-
GTA IV bolsters Take-Two sales
Take-Two, the video game publisher in takeover talks with rival Electronic Arts, reported a third quarter sales boost from its Grand Theft Auto IV title...
-
Dechra takes dog medicine to US
The veterinary products maker will be marketing its best-selling dog medicine in the US next year, building on its recent expansion into Europe
-
Big pharma gravitates to the academe
Drug companies are increasingly looking outside their own walls for scientific discoveries by partnering with academic institutions, and universities are eager to receive support
-
Japan's Shionogi to buy Sciele Pharma
Japanese drug maker Shionogi & Co plans to buy U.S.-based Sciele Pharma Inc for $1.4bn as it seeks to expand in the key US market
-
QIA to take control of health group
The Senad Group, a major operator in the UK special educational needs market, is the smallest of the four investments made by the Qatari Investment Authority through Three Delta
-
Skyepharma close to renegotiating bonds
The maker of drug delivery systems, Skyepharma, is close to an agreement to renegotiate its bonds, as it announced a reduction in losses and increased revenues
-
Mind the gap
Britain's poor need to be helped to healthier habits. More than new hospitals, preventative campaigns are what the UK needs to close its health gap
-
Bupa profits dented by Irish exit
Profits at BUPA have been dented by its exit from the Irish market last year, although its core insurance business continues to grow
-
Cell advance offers medical benefits
A biological breakthrough could lead to a cure for diabetes and has profound implications for regenerative medicine ? replacing diseased or injured tissues with new ones in good working order
-
Hospitals welcome private sector visits
Western clinics and medical schools are helping to plug the Gulf's healthcare gap
-
GI Partners beds down with Care Aspirations
The Anglo-American group's move underlines how the defensive qualities of the psychiatric care market are proving increasingly attractive to buy-out investors
-
King Pharma raises pressure on rival
Drugmaker says Alpharma rejected a $1.4bn unsolicited takeover offer it made this month, prompting the suitor to reveal details of the bid publicly
-
Cinven drops out of auction process for EDT
The number of bidders for Elan Drug Technologies, a subsidiary of the Irish pharmaceuticals company, has narrowed after Cinven dropped out of the auction
|
|
Brain feed